Michael Scolaro

Michael Scolaro

Sep 27, 2017

Group 6 Copy 117
2
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Antibiotics and Affect: Avenues for Addiction Management

Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...

Community-based Leishmaniasis research in Sri Lanka

Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...

Modeling Zika virus transmission from mother to child using uterine mini-organs

As of mid-2019, 87 countries have had or still have Zika cases, underlining the importance of this infectious...

Backer Badge Funded